105 related articles for article (PubMed ID: 7714775)
1. Oral administration of clotrimazole and blockade of human erythrocyte Ca(++)-activated K+ channel: the imidazole ring is not required for inhibitory activity.
Brugnara C; Armsby CC; Sakamoto M; Rifai N; Alper SL; Platt O
J Pharmacol Exp Ther; 1995 Apr; 273(1):266-72. PubMed ID: 7714775
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Ca(2+)-dependent K+ transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives.
Brugnara C; de Franceschi L; Alper SL
J Clin Invest; 1993 Jul; 92(1):520-6. PubMed ID: 8326017
[TBL] [Abstract][Full Text] [Related]
3. Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease.
Brugnara C; Gee B; Armsby CC; Kurth S; Sakamoto M; Rifai N; Alper SL; Platt OS
J Clin Invest; 1996 Mar; 97(5):1227-34. PubMed ID: 8636434
[TBL] [Abstract][Full Text] [Related]
4. Treatment with oral clotrimazole blocks Ca(2+)-activated K+ transport and reverses erythrocyte dehydration in transgenic SAD mice. A model for therapy of sickle cell disease.
De Franceschi L; Saadane N; Trudel M; Alper SL; Brugnara C; Beuzard Y
J Clin Invest; 1994 Apr; 93(4):1670-6. PubMed ID: 7512989
[TBL] [Abstract][Full Text] [Related]
5. Clotrimazole enhances lysis of human erythrocytes induced by t-BHP.
Lisovskaya IL; Shcherbachenko IM; Volkova RI; Ataullakhanov FI
Chem Biol Interact; 2009 Aug; 180(3):433-9. PubMed ID: 19394317
[TBL] [Abstract][Full Text] [Related]
6. The antifungal imidazole clotrimazole and its major in vivo metabolite are potent blockers of the calcium-activated potassium channel in murine erythroleukemia cells.
Rittenhouse AR; Vandorpe DH; Brugnara C; Alper SL
J Membr Biol; 1997 May; 157(2):177-91. PubMed ID: 9151659
[TBL] [Abstract][Full Text] [Related]
7. ICA-17043, a novel Gardos channel blocker, prevents sickled red blood cell dehydration in vitro and in vivo in SAD mice.
Stocker JW; De Franceschi L; McNaughton-Smith GA; Corrocher R; Beuzard Y; Brugnara C
Blood; 2003 Mar; 101(6):2412-8. PubMed ID: 12433690
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology of the human red cell voltage-dependent cation channel; Part I. Activation by clotrimazole and analogues.
Barksmann TL; Kristensen BI; Christophersen P; Bennekou P
Blood Cells Mol Dis; 2004; 32(3):384-8. PubMed ID: 15121096
[TBL] [Abstract][Full Text] [Related]
9. Differences in the actions of some blockers of the calcium-activated potassium permeability in mammalian red cells.
Benton DC; Roxburgh CJ; Ganellin CR; Shiner MA; Jenkinson DH
Br J Pharmacol; 1999 Jan; 126(1):169-78. PubMed ID: 10051133
[TBL] [Abstract][Full Text] [Related]
10. Clotrimazole and efaroxan inhibit red cell Gardos channel independently of imidazoline I1 and I2 binding sites.
Coupry I; Armsby CC; Alper SL; Brugnara C; Parini A
Eur J Pharmacol; 1996 Jan; 295(1):109-12. PubMed ID: 8925867
[TBL] [Abstract][Full Text] [Related]
11. Selective blockade of the intermediate-conductance Ca2+-activated K+ channel suppresses proliferation of microvascular and macrovascular endothelial cells and angiogenesis in vivo.
Grgic I; Eichler I; Heinau P; Si H; Brakemeier S; Hoyer J; Köhler R
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):704-9. PubMed ID: 15662023
[TBL] [Abstract][Full Text] [Related]
12. Novel inhibitors of the Gardos channel for the treatment of sickle cell disease.
McNaughton-Smith GA; Burns JF; Stocker JW; Rigdon GC; Creech C; Arrington S; Shelton T; de Franceschi L
J Med Chem; 2008 Feb; 51(4):976-82. PubMed ID: 18232633
[TBL] [Abstract][Full Text] [Related]
13. A novel type of ATP block on a Ca(2+)-activated K(+) channel from bullfrog erythrocytes.
Shindo M; Imai Y; Sohma Y
Biophys J; 2000 Jul; 79(1):287-97. PubMed ID: 10866955
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy of erythropoietin, hydroxyurea, and clotrimazole in a beta thalassemic mouse: a model for human therapy.
de Franceschi L; Rouyer-Fessard P; Alper SL; Jouault H; Brugnara C; Beuzard Y
Blood; 1996 Feb; 87(3):1188-95. PubMed ID: 8562946
[TBL] [Abstract][Full Text] [Related]
15. S-allyl cysteine in combination with clotrimazole downregulates Fas induced apoptotic events in erythrocytes of mice exposed to lead.
Mandal S; Mukherjee S; Chowdhury KD; Sarkar A; Basu K; Paul S; Karmakar D; Chatterjee M; Biswas T; Sadhukhan GC; Sen G
Biochim Biophys Acta; 2012 Jan; 1820(1):9-23. PubMed ID: 22033380
[TBL] [Abstract][Full Text] [Related]
16. Clotrimazole-sensitive K+ currents regulate pacemaker activity in interstitial cells of Cajal.
Zhu Y; Ye J; Huizinga JD
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1715-25. PubMed ID: 17347448
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of intermediate-conductance Ca2+-activated K+ channel and cytoprotective properties of 4-piperidinomethyl-2-isopropyl-5-methylphenol.
Shen AY; Tsai JH; Teng HC; Huang MH; Wu SN
J Pharm Pharmacol; 2007 May; 59(5):679-85. PubMed ID: 17524233
[TBL] [Abstract][Full Text] [Related]
18. The action of blocking agents applied to the inner face of Ca(2+)-activated K+ channels from human erythrocytes.
Dunn PM
J Membr Biol; 1998 Sep; 165(2):133-43. PubMed ID: 9745001
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic strategies for prevention of sickle cell dehydration.
Brugnara C
Blood Cells Mol Dis; 2001; 27(1):71-80. PubMed ID: 11358364
[TBL] [Abstract][Full Text] [Related]
20. A new therapeutic approach for sickle cell disease. Blockade of the red cell Ca(2+)-activated K+ channel by clotrimazole.
Brugnara C; De Franceschi L; Armsby CC; Saadane N; Trudel M; Beuzard Y; Rittenhouse A; Rifai N; Platt O; Alper SL
Ann N Y Acad Sci; 1995 Jul; 763():262-71. PubMed ID: 7677336
[No Abstract] [Full Text] [Related]
[Next] [New Search]
